60 Degrees Pharmaceuticals Announces 2024 Annual Results


WASHINGTON, March 28, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, reported today their financial results for the 2024 fiscal year, ended December 31, 2024.

Go here to read the rest:
60 Degrees Pharmaceuticals Announces 2024 Annual Results

Related Posts